chrisvoncsefalvay/vaers-outcomes huggingface dataset:
about 2-3 days after the vaccination I started feeling a sensation of pins & needles on my toes & hands. It was not a constant feeling and changing from one place to another. These symptoms still persist 3 weeks after although the feeling now is more of a spread out type of tingling sensation or mild numbness at hands & feet whereas at the beginning was more of pin localized feeling here and there.  Some days I have the feeling has been better but overall it comes back and I really wonder how long will it last and what can I do about it, especially when planing for an IVF procedure in few weeks.
Case number PHEH2015US003469, is an initial spontaneous report from a medical assistant received on 18 FEB 2015. This report refers to a 53 years old female patient. Medical history and concomitant medications were not reported. On 12 FEB 2015, the patient mistakenly received FLUVIRIN 2014/2015 (batch number: 1410801) intradermally instead of PPD (tuberculin) skin test. No adverse event was reported.
Systemic: Dizziness / Lightheadness-Medium, Additional Details: After the patient's 15 minutes observation time was up, the patient complained of dizziness. We asked her to sit down for longer and got her water. Her blood pressure was taken, reading: 146/97. She stated she only had soup to eat before her evening vaccine appointment. She did not have any reaction/problems with her first 2 doses (this was her booster). The patient did not have any relatives or friends call. She insisted to leave after I asked she stay longer or I call her a ride.
High fever, chills, rigor, profuse sweating, joint and muscle pain, severe headache.
1st shot no issues except injection pain. 2nd shot ok by awakened with swelling left hand/ wrist- weak after. Left arm pain as well.
My monthly menstrual cycle is always on time and it arrived 6.5 days early; Stomach cramps; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6202) via an unspecified route of administration in the left arm on 09Mar2021 at 09:45 (age the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, heart murmur, full thyroidectomy and low back pain. Allergies to medications, food, or other products was reported to apples, MRI contrast dye. Concomitant medications included levothyroxine (SYNTHROID), ibuprofen (ADVIL) and albuterol (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, at 14:00, the patient's menstrual cycle (which was always on time) had arrived 6.5 days earlier with severe stomach cramps (the patient would usually get only lower back pain). The patient did not receive treatment for the reported events. The clinical outcome of menstrual cycle shortened and stomach cramps was unknown.   No follow-up attempts are needed. No further information is expected.
Pt recv vax on 1/21/99; on 1/25/99 pt exp swelling of right face, cough, sore throat & vomiting
At around 7pm that evening of the vaccine, I started running a fever (101). When I woke up in the a:m, I felt very tired and when I started walking I felt like I needed bilateral knee replacement (bone on bone rubbing). This lasted about 8 hours then went away. Six weeks after the vaccine, I experienced an episode of tachycardia and went to the ER. My HR was super high and they did numerous tests and bloodwork, but couldn't explain the high HR. Told me to see a cardiologist who did a stress test which came back positive. I had a bunch of heart imaging done and they determined that the left side of my heart was not contracting properly. I had a heart catheterization to determine the cause, which came back inconclusive. So, they determined I had unexplained tachycardia and I was put on a bunch of heart meds. It took 3 months for me to start feeling normal again, and I am continuing to monitor with a cardiologist. In June, my left knee swelled up and I had a torn meniscus (did not have any trauma to cause this). I had to have surgery to repair it. After surgery, I developed a DVT and had to be put on Eliquis, and am still on it.
30 minutes after inoculation, individual complain of nausea and tightness in throat. Vaccine administer gave individual two Benadryl and had her consume liquids. Individual complained the she could not breath prompting vaccine administer to administer 50 mg Epipen. EMS was called and individual was taken to emergency room.
tested positive for COVID-19; Loss of taste; Loss of smell; difficulty breathing; aching all over; joint pain; very fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing) and MYALGIA (aching all over) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient did not have any medical history.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing), MYALGIA (aching all over), ARTHRALGIA (joint pain), FATIGUE (very fatigue) and PYREXIA (fever). On 24-Mar-2021, AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), DYSPNOEA (difficulty breathing), MYALGIA (aching all over), ARTHRALGIA (joint pain) and PYREXIA (fever) had resolved. At the time of the report, COVID-19 (tested positive for COVID-19) outcome was unknown and FATIGUE (very fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. No treatment information was provided. It was reported that the patient still felt tired at the time of report. The patient was scheduled for second dose on 03-Apr-2021.
After the first vaccine, had problems with balance that resulted in a fall and hip fracture. After the second vaccine, had much fatigue on  day 1 after the shot; on day 2 had bad headache and fatigue; day 3 was nauseous all day and vomited once so did not eat much; day 4 had Diarrhea nausea vomiting. Moving my head seems to be causing nausea  and vomiting so trying to keep it still. Have not been able to do much since getting the shot. Writing this report on day 4 after the shot.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 36 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: The patient had anti viral Paxlovid treatment for COVID 19 started on 19Jul2022 and stopped on 24Jul2022. The patient's dose 4 lot no. was now available/provided to reporter at the time of report completion. The patient had rebound of covid symptoms after day 10. The patient had adverse event on 27Jul2022 at 12:15 pm, of which outcome was recovering. No other medication in 2 weeks.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded.
pt recv vax&exp 4 or 5 chicken pox lesions;no further details were provided;pt also reported 2 children WAES 96031479&96031480
86yo female alert, stable with ankle abrasion eating 100% prior to vaccine in assisted living facility.   On 2/1/2021, received Moderna vaccine.  Starting thereafter, eating 50% on 2/2/21. Temperature was 98 tympanic.   On 2/3, the leg abrasion started having moderate bleeding.  On 2/4, the caregiver noted patient "not looking good, unable to talk, arms moving aimlessly, grasping".  BP 95/41, temperature 98,  oxygen on room air 92-93%.  POA did not want hospital transfer.  2/5 Hospice started, oxygen given, morphine given.   2/5-2/8 comfort care given, patient responsive to tactile stimuli, resting, not taking oral medications or food.  2/8/2021 patient expired.
Patient was admitted for fall and pain in her left lower extremity after a fall. No syncope. No loss of consciousness. The patient came in by ambulance and looks like she has multiple falls recently. Creatinine was 1.4 in the ER. Total CPK was 189. CT cervical spine had no acute abnormality. The patient was admitted to the hospital for further evaluation. She received IV fluid. Her troponin was slightly elevated at 468, but was trending down likely secondary to chronic kidney disease stage II. COVID POSITIVE ACCIDENTALLY ON ROOM AIR ASYMPTOMATIC. She received Monoclonal antibody treatment, she was discharged once stable.
Nausea: onset 10/10 8 PM - has continued for 2 days now. Headache: onset 10/10 9:30 PM - quit after sleep Body aches: onset 10/11 6:30 AM - 10/12 6:30 AM Swelling/pain at injection site: onset 10/10-10/11.
Systemic: broken blood vessels-Mild, Additional Details: pt reported broken blood vessels near/on left eye
Varicella site LOA red, swollen painful, hot to touch, child has no fever. Area feels itchy otherwise child fine. Also received Hep B RD no signs of problems there.
Red rash with inflammation  developed on both arms on the vaccine day.  Today, two weeks after vaccine the rash still present. Benadryl didn?t help.
Patient had severe pain in left arm beginning the night of vaccination, describes as 9/10 in severity with any motion. Maintained this level of pain for about 3 days, interrupting his sleep. Experienced numbness and tingling in the R hand intermittently during this time. Now 5 days later, the pain is 2/10 at rest and 7/10 with motion.
Pt left clinic and shopped in the store, she returned to the clinic approx 10 minutes and reported that her face felt "weird" like when she has allergic rx to coconut in the past. I had pt come to clinic and lay down, took vital signs, I called my medical director and followed his recommendation to give pt 50 mg of oral Benadryl. I called 911 and they came to examine pt. Pt declined transportation by EMS to ER but stated she was going to the ER and waited in the clinic until her friend could drive her to the ER which was approx 20 minutes after EMS left clinic.
Patient became lightheaded and dizzy. She fell forward and struck her teeth on the floor. Small amount of blood in patient's mouth. Patient was monitored by RN and MD. Initial BP 96/60. Patient drank water. BP returned to normal range within 10 minutes. Patient monitored for 40 minutes and was feeling normal again. Mom took her home.
Information has been received from a physician concerning a 24 month old female patient who on 16-JUL-2009 was vaccinated subcutaneously with the first dose of 0.5 ml MMR II (lot # 663164/1583X).  Concomitant therapy included VAQTA, VARIVAX (MSD).  Other concomitant therapy included DTAP.  On 27-JUL-2009 the patient developed "a measles-like rash that covered about 80 percent of her body."  The patient had sought medical attention via office visit.  Additional information has been requested.
Information has been received from a 26 year old female medical assistant (not CMA) with migraines, sulfonamide allergy and drug hypersensitivity to over the counter cold medications, who on 27-SEP-2006, was vaccinated IM with a 0.5ml dose of HPV (lot # 653735/0688F). Concomitant therapy included ethinyl estradiol/norethindrone (OVCON 35), netaxalone (SKELAXIN) and acetaminophen/hydrocodone bitartrate (VICODIN TABLETS). On 27-SEP-2006, the patient experienced severe pain at the injection site while the medication was being injected. The medical assistant also reported the pain as a sore bruised feeling that lasted for 4 to 5 days. On approximately 27-SEP-2006, the patient also experienced slight fever for 4 to 5 days. On 04-OCT-2006, she had physical therapy and the sore bruised feeling came back. Subsequently, the medical assistant recovered, however it was unknown if she recovered from the sore bruised feeling that came back on 04-OCT-2006. There was no product quality complaint involved. The patient sought unspecified medical attention. Additional information has been requested.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 0392KKOA) for COVID-19 vaccination.     The patient's past medical history included Epstein-Barr virus infection. Concurrent medical conditions included RA (suspected rheumatoid arthritis and patient has joint problems).   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter. This case concerns a 71-year-old female with serious unexpected event of pain in extremity. Event latency 2 days after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-235912 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Medical history, labs and treatment details were corrected. Outcome of the event was corrected to resolved.; Sender's Comments: This case concerns a 71-year-old female with serious unexpected event of pain in extremity. Event latency 2 days after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. This event appears to be non-serious as it resolved with no medical intervention.
Information has been received from a pharmacist referring to a patient of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On 19-JUL-2016, the patient was vaccinated with a dose of improperly stored ZOSTAVAX 19400 plaque forming units (PFU) (lot # L036823 with expiration date 24-DEC-2016; dose and route were not reported). The vaccine was improperly stored at 12 degree Fahrenheit for 4 months. There was no previous temperature excursion and no data logger was involved. No adverse effect was reported. This is one several reports received from the same reporter. Additional information has been requested.
within 18 hours after dose at 12:00 pm, fever (up to 101-102), chills, fatigue, nausea, no appetite. In addition, acute asthma attack with need for rescue inhaler due to tight chest, cough, wheezing. Slept most of the day on 3/13/2021. Woke up on Sunday, 3/14/2021, felt slightly better in morning. By noon, fever, chills, nausea, fatigue, no appetite. Still required inhaler as presented with cough and wheezing. Symptoms lasted all day and evening. Woke up on Monday, 3/15, still coughing, wheezing, felt fatigued, no appetite, nausea and diarrhea. No fever. No symptoms by Tuesday, 3/16.
Evening of shot - arm very painful to move. Headache, backache, felt feverish next day - upper arm red, swollen, hot from shoulder to middle. Following day redness, swelling and feeling hot extended to below elbow and around back and side of upper arm. Upper part improving, Mild itching throughout 10-17 - Improving 10-19-ok
Child developed swelling, redness and warmth with induration at left deltoid (5cm x 6cm) ~12 hrs-20hrs after immunization with DTaP and IPV at that site. Re-eval pending.
Pt recv vax on 9/22/98; later the same dy pt exp erythematous swelling (5 x 7 cm) mildly indurated &tender of RL.
Almost constant headaches since the vaccine.  Primarily in the front part of my head, strongest in the front left.  Very rare to ever have a headache in my entire life prior to the vaccine.
Headache, Myalgia, Left arm soreness, headaches, decreased appetite Narrative:
Information has been received from a certified medical assistant referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction/allergies reported. Since January 2016 the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (lot # L044526 with expired date 09-NOV-2017, digital data logger, dose and route were unknown). No concomitant therapy was reported. The improperly stored vaccines were stored under 30.2 F for 2 hours and there was no previous temperature excursion. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
I noticed that I had a rash under my right breast on my torso and I thought it was heat rash, I didn't know. It turns out that I was having a shingles outbreak. I got a little rash on my side and on my back (like it wrapped around on one side). I noticed it and then I called the office. It was closed. On call physician's assistant - gave a televisit - prescribed to me - Valacyclovir - for treating shingles. I had taken photos of it. Took it for 7 days and took the rest of the week off from work. By the end of July, my symptoms were pretty much resolved. I saw my acupuncturist also and he gave me a salve to apply to rash. That helped a lot - it was a blend of Herbs. It worked like a charm. Did follow up with PA.
hurt me; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received old vaccine on an unknown date). Family history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced pain (Verbatim: hurt me). The outcome of the pain was resolved (duration 4 days).   It was unknown if the reporter considered the pain to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 15-JUN-2023 The case was received from the consumer interactive digital media. The patient stated that take the vaccine, it hurt him/her a little for 4 days, but it was better to than having Shingles disease.  When there was no vaccine yet, people topped to check that the shingles was not following it, heating a silver spoon and applying it on the skin, the spoon had to be of silver, it was a strong cure, but it stopped it.  The patient stated that physician cured his/her mother like this, it started in the middle of the chest and it reached till the middle of the back, but it did not progress any further.  As soon as the first vaccine was launched a few years ago, patient got vaccine and now he/she had got the new one, which was two vaccines.  The patient requested to get vaccinated. The follow-up could not be possible as no contact details were available.
Onset of dizziness, weakness & nausea during the night after admin. Weakness worse in am. Nausea all day. Dizziness worse at night. Fatigue & malaise.
pt recv vax & w/in 5min post vax neck hurt & lt side between scapula & spine was tender;seen by MD who said had swollen glands in neck & armpit & enlarged spleen;
Information has been received from a physician and the daughter of a 73 year old female with arthritis, high blood pressure and reaction to prednisone, who on 28-MAY-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  Concomitant therapy included naproxen, ACTONEL, atenolol, LASIX (furosemide), potassium (unspecified), amitriptyline hydrochloride (manufacturer unknown), ranitidine, calcium (unspecified) (+) vitamin D (unspecified) and lovastatin (manufacturer unknown).  The daughter reported that her mother received ZOSTAVAX (Oka/Merck) on her right arm and the next day, on 29-MAY-2008 she could not move her left leg.  Her hip was very painful down to her leg.  On 02-JUN-2008, the patient developed pain on the right leg.  The daughter reported that her mother went to the doctor.  The physician reported that it was equivalent to a toothache but at the left hip and leg; and that she had a headache and felt woozy with no fever.  The physician reported that the patient's CPK was 13.64, C-reactive protein was 0.2 and sedimentation rate was 13.  The patient was prescribed dexamethasone 4 mg daily.  The patient was unable to walk without taking pain pills because her leg hurt too much, and that morning the pain was worse and had spread to her back.  On 03-JUN-2008, her lovastatin (manufacturer unknown) was discontinued.  On 04-JUN-2008, her laboratory results were CPK 6.73, creatinine 1.36, slight increase in uric acid, and urine was clean.  On 06-JUN-2008, more laboratory results were pending including CPK and metabolic panels.  Dexamothasone was increased to 4mg twice daily coupled with LORTAB 5 mg every 6 hours.  At the time of the report, the patient continued to have pain at the left leg extending the hip.  Follow up information was received from the physician reporting that on 12-JUN-2008, the patient had an MRI which showed a "lesion in the lumbar spine with borderline spinal stenosis at L4-L5".  On 10-JUN-2008, the patient's CPK rate had normalized at 83 (1 week after the shot).  No further information is available.
Headaches. Intermittent. Right side of head. First mild HA 1/8. Second more intense HA 1/12 3AM , right side right orbital space. Dull headache.
Pt. return to clinic - localized reaction. Induration size of 25 cents, redness 2 1/2 in x 2 1/2 in. Advised to use cool compress, TYLENOL or BENADRYL.
Patient received Moderna vaccine on 1/28/21. She inadvertently received the Pfizer vaccine on 2/25/21 (Lot number EL9266, given IM in left deltoid). It was not noted that this happened until 3/2/21. Medical director called, Dr., who in turn notified the other Medical director. Patient called on 3/3/21 and left message. Spoke to patient on 3/4/21 with Dr. on phone. Notified patient what happened and that did not need to have any vaccines repeated according to CDC guidelines. Patient had not any untoward SE from receiving 2 different brands of the COVID vaccine.